3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
23
Lymphoma
16
Osteosarcoma
11
Lymphoma, Large B-Cell, Diffuse
11
Hodgkin Disease
11
Testicular Neoplasms
10
Lymphoma, Non-Hodgkin
10
Teratoma
8
Ovarian Neoplasms
7
Testicular Germ Cell Tumor
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Neoplasms
6
Burkitt Lymphoma
6
Recurrence
5
Endodermal Sinus Tumor
5
Central Nervous System Neoplasms
5
Carcinoma, Embryonal
5
Lymphoma, Large-Cell, Anaplastic
4
Seminoma
3
Rhabdomyosarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Germ Cell Cancer
3
Neurofibrosarcoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell
3
Histiocytoma, Malignant Fibrous
3
Fibrosarcoma
3
Vomiting
2
Sarcoma, Synovial
2
Sarcoma, Alveolar Soft Part
2
Interventions
Dexamethasone
17
Melphalan
14
Bortezomib
10
Calcium Dobesilate
8
Filgrastim
6
Granulocyte Colony-Stimulating Factor
5
Cyclophosphamide
5
birtamimab
4
dexamethasone acetate
3
Whole-Body Irradiation
3
Thalidomide
3
Peripheral Blood Stem Cell Transplantation
3
Lenalidomide
3
fludarabine phosphate
2
daratumumab
2
Mycophenolic Acid
2
Etoposide
2
Doxycycline
2
Darbepoetin alfa
2
Cyclosporine
2
Busulfan
2
Blood Component Removal
2
pomalidomide
1
pegfilgrastim
1
ixazomib
1
isatuximab
1
ferrous sulfate
1
ferric gluconate
1
dexamethasone 21-phosphate
1
carfilzomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoglobulin Light-chain Amyloidosis
×
Ifosfamide
×
Clear all
No trials found.